Femasys Correlations
FEMY Stock | USD 1.01 0.03 3.06% |
The current 90-days correlation between Femasys and Precision Optics, is -0.17 (i.e., Good diversification). The correlation of Femasys is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Femasys Correlation With Market
Modest diversification
The correlation between Femasys and DJI is 0.24 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Femasys and DJI in the same portfolio, assuming nothing else is changed.
Femasys |
Moving together with Femasys Stock
Moving against Femasys Stock
0.71 | GH | Guardant Health | PairCorr |
0.38 | CAH | Cardinal Health | PairCorr |
0.33 | LH | Laboratory | PairCorr |
0.42 | UTMD | Utah Medical Products | PairCorr |
0.36 | NEOG | Neogen | PairCorr |
0.32 | RDNT | RadNet Inc | PairCorr |
0.51 | VCEL | Vericel Corp Ord | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Femasys Stock performing well and Femasys Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Femasys' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
POCI | 3.41 | 0.04 | 0.01 | 0.12 | 4.02 | 7.48 | 18.59 | |||
KRMD | 2.60 | 0.76 | 0.22 | 3.96 | 2.28 | 6.37 | 18.56 | |||
INFU | 3.09 | 0.51 | 0.18 | 0.34 | 2.69 | 7.64 | 22.10 | |||
UTMD | 0.69 | (0.14) | 0.00 | (0.08) | 0.00 | 1.17 | 7.07 | |||
MLSS | 2.91 | (0.45) | 0.00 | (0.57) | 0.00 | 7.53 | 27.59 | |||
PDEX | 3.78 | 1.31 | 0.26 | 0.86 | 3.87 | 9.99 | 28.08 | |||
CLPBY | 1.16 | (0.11) | 0.00 | (0.23) | 0.00 | 1.96 | 5.64 | |||
OPSSF | 2.43 | 0.27 | 0.05 | (0.50) | 2.41 | 5.50 | 19.98 | |||
SAUHY | 1.71 | (0.23) | 0.00 | (3.19) | 0.00 | 3.19 | 12.55 |
Femasys Corporate Management
Steven Damon | VP Devel | Profile | |
James MD | Chief Officer | Profile | |
Richard Spector | Chief Officer | Profile | |
Christine Thomas | Senior Affairs | Profile | |
Dov Elefant | Chief Officer | Profile | |
Todd MBA | Chief Advisor | Profile |